Biotech · Private company
Fujifilm Pharmaceuticals U.S.A., Inc.
Track this companyFree. Adds Fujifilm Pharmaceuticals U.S.A., Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials83 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- FavipiravirPhase 2 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- FF-10501-01Phase 2 · AMLClinicalTrials.gov · fetched Nov 12, 2026
- FF-10502-01Phase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- FF-10832Phase 2 · Advanced Urothelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · Advanced Urothelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- FF-10101-01Phase 1 · AML, AdultClinicalTrials.gov · fetched Nov 12, 2026
- FF-10832 Gemcitabine Liposome InjectionPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- FF-10850 Topotecan Liposome InjectionPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- FF21101Phase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- A Study to Evaluate Safety, Efficacy of FF-10832 in Combo With Pembrolizumab in Urothelial & Non-small Cell Lung CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Jun 1, 2022ClinicalTrials.gov NCT05318573 · fetched Nov 12, 2026
- Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19PHASE2 · COMPLETED · started Apr 17, 2020ClinicalTrials.gov NCT04358549 · fetched Nov 12, 2026
- A Study of FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors Including Merkel Cell CarcinomaPHASE1 · ACTIVE_NOT_RECRUITING · started Nov 14, 2019ClinicalTrials.gov NCT04047251 · fetched Nov 12, 2026
- A Phase 1 Dose-escalation Study of FF-10832 for Treatment of Solid Tumors Including Biliary Tract CancerPHASE1 · ACTIVE_NOT_RECRUITING · started Mar 22, 2018ClinicalTrials.gov NCT03440450 · fetched Nov 12, 2026
- Study of FF-10101-01 in Patients With Relapsed or Refractory Acute Myeloid LeukemiaPHASE1 · COMPLETED · started May 5, 2017ClinicalTrials.gov NCT03194685 · fetched Nov 12, 2026
- A Dose Escalation Study of Radio-labeled Antibody for the Treatment of Advanced CancerPHASE1 · COMPLETED · started Jan 1, 2016ClinicalTrials.gov NCT02454010 · fetched Nov 12, 2026
- Study of FF-10502-01 in Patients With Advanced Solid Tumors and LymphomasPHASE1_PHASE2 · COMPLETED · started Jan 1, 2016ClinicalTrials.gov NCT02661542 · fetched Nov 12, 2026
- Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological MalignanciesPHASE1_PHASE2 · COMPLETED · started Jul 1, 2014ClinicalTrials.gov NCT02193958 · fetched Nov 12, 2026